Australian start-up Cortical Labs and UK’s bit.bio have built CL1 with the aim of creating ‘synthetic biological intelligence’ ...

What we tried, what didn't work and how a combination of approaches eventually helped us build a reliable computer vision ...

The global clinical trials market size was valued at USD 60.56 billion in 2024 and is expected to be worth around USD 95.60 ...